Literature DB >> 219249

In vitro, the major ribosome binding site on Rous sarcoma virus RNA does not contain the nucleotide sequence coding for the N-terminal amino acids of the gag gene product.

J L Darlix, P F Spahr, P A Bromley, J C Jaton.   

Abstract

Ribosomes from the reticulocyte lysate bind strongly and mainly to a region located in the 5' end of the Rous sarcoma virus RNA molecule between residues 9 and 53. This binding involves the participation of initiator tRNA and is sensitive to inhibitors of initiation of protein synthesis such as 7-methyl-GMP and aurintricarboxylic acid. The nucleotide sequence of this ribosome binding site has been determined: it conatains a GUG codon centered at position 26 that is not in phase with any termination codon within the 5' end nucleotide sequence of the RNA that we have analyzed (101 residues). However, the predicted N-terminal amino acid sequence starting from this GUG codon (or even from any AUG or GUG codon in the 5' end of the RNA) does not coincide with that of the in vitro-synthesized product of the 5' end proximal gag gene. Nevertheless, inhibition of ribosome binding to this site is accompanied by an inhibition of the in vitro translation of the gag gene.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 219249      PMCID: PMC353193     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Evidence for splicing of avian sarcoma virus 5'-terminal genomic sequences into viral-specific RNA in infected cells.

Authors:  R A Krzyzek; M S Collett; A F Lau; M L Perdue; J P Leis; A J Faras
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

2.  Characterization of the ribosome-protected regions of 125I-labelled rabbit globin messenger RNA.

Authors:  S Legon
Journal:  J Mol Biol       Date:  1976-09-05       Impact factor: 5.469

3.  The binding of 125I-labelled rabbit globin messenger RNA to reticulocyte ribosomes.

Authors:  S Legon; H D Robertson
Journal:  J Mol Biol       Date:  1976-09-05       Impact factor: 5.469

4.  Prevention of NH2-terminal acetylation of proteins synthesized in cell-free systems.

Authors:  R D Palmiter
Journal:  J Biol Chem       Date:  1977-12-25       Impact factor: 5.157

5.  Structure-function relationship of 5' non-coding sequence of rabbit alpha- and beta-globin mRNA.

Authors:  F E Baralle
Journal:  Nature       Date:  1977-05-19       Impact factor: 49.962

6.  Rous sarcoma virus genome is terminally redundant: the 5' sequence.

Authors:  W A Haseltine; A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

7.  A joint produce of the genes gag and pol of avian sarcoma virus: a possible precursor of reverse transcriptase.

Authors:  H Oppermann; J M Bishop; H E Varmus; L Levintow
Journal:  Cell       Date:  1977-12       Impact factor: 41.582

8.  Conservation of the primary structure at the 3' end of 18S rRNA from eucaryotic cells.

Authors:  O Hagenbüchle; M Santer; J A Steitz; R J Mans
Journal:  Cell       Date:  1978-03       Impact factor: 41.582

9.  Extensive in vitro transcription of rous sarcoma virus RNA by avian myeloblastosis virus DNA polymerase and concurrent activation of the associated RNase H.

Authors:  J L Darlix; P A Bromley; P F Spahr
Journal:  J Virol       Date:  1977-09       Impact factor: 5.103

10.  New procedure for the direct analysis of in vitro reverse transcription of Rous sarcoma virus RNA.

Authors:  J L Darlix; P A Bromley; P F Spahr
Journal:  J Virol       Date:  1977-04       Impact factor: 5.103

View more
  23 in total

1.  Rous sarcoma virus translation revisited: characterization of an internal ribosome entry segment in the 5' leader of the genomic RNA.

Authors:  C Deffaud; J L Darlix
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Evidence for the identity of shared 5'-terminal sequences between genome RNA and subgenomic mRNA's of B77 avian sarcoma virus.

Authors:  C M Stoltzfus; L K Kuhnert
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

3.  New procedure for isolation of Rous sarcoma virus-specific RNA from infected cells.

Authors:  P A Bromley; P F Spahr; J L Darlix
Journal:  J Virol       Date:  1979-07       Impact factor: 5.103

4.  A comparison of eukaryotic viral 5'-leader sequences as enhancers of mRNA expression in vivo.

Authors:  D R Gallie; D E Sleat; J W Watts; P C Turner; T M Wilson
Journal:  Nucleic Acids Res       Date:  1987-11-11       Impact factor: 16.971

5.  Autogenous regulation of RNA translation and packaging by Rous sarcoma virus Pr76gag.

Authors:  T S Sonstegard; P B Hackett
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

6.  A study of the dimer formation of Rous sarcoma virus RNA and of its effect on viral protein synthesis in vitro.

Authors:  E Bieth; C Gabus; J L Darlix
Journal:  Nucleic Acids Res       Date:  1990-01-11       Impact factor: 16.971

7.  Cloning and nucleotide sequences of cDNAs spanning the splice junctions of Rous sarcoma virus mRNAs.

Authors:  L J Chang; C M Stoltzfus
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

8.  Characterization of ribosome binding on Rous sarcoma virus RNA in vitro.

Authors:  R B Petersen; P B Hackett
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

9.  Transduction of the cellular src gene and 3' adjacent sequences in avian sarcoma virus PR2257.

Authors:  J Geryk; P Dezélée; J V Barnier; J Svoboda; J Nehyba; I Karakoz; A V Rynditch; B A Yatsula; G Calothy
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

10.  Analysis of the secondary and tertiary structures of Rous sarcoma virus RNA.

Authors:  J L Darlix; M Schwager; P F Spahr; P A Bromley
Journal:  Nucleic Acids Res       Date:  1980-08-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.